OPINION
PARP inhibitors show potential to transform understanding of cancer
NBC News Jun 25, 09 9:12 AM CDT
(Newser Summary) -
A new class of drugs in development represents the biggest cancer breakthrough in a decade, Robert Bazell writes at NBC. In a study causing much excitement in the medical world, breast, ovarian, and prostate cancer patients treated with Olaparib, one of a group of drugs known as PARP inhibitors, had their tumors shrink or vanish, often without the punishing side effects caused by other cancer treatments.
More »